Email this article SOME FACTORS RELATED TO HYPERGLYCEMIA IN CANCER PATIENTS IN THAI NGUYEN NATIONAL HOSPITAL
About this article
Received: 26/05/20 Revised: 08/07/20 Published: 10/07/20Authors
1. Nguyen Thi Hoa
, TNU - University of Medicine and Pharmacy2. Le Thi Huong Lan, Thai Nguyen National Hospital
3. Tran Thi Kim Phuong, TNU - University of Medicine and Pharmacy
Abstract
This study aims to analyze some factor related to hyperglycemia in cancer patients in Thai Nguyen National Hospital. By a longitudinal study method of 266 cancer patients were treated at least 3 cycles of chemotherapy. The results show that prechemotherapy, after the 3rd cycle, the mean concentration of plasma glucose levels respectively were 4.97±0.45 mmol/L, 5.33±0.99 mmol/L, 5.44±1.12 mmol/L, with statistically significant differences. After the 3rd cycle, the prevalence of hyperglycemia in patients with colon cancer, in patients treated with 5FU, in patients treated with FOLFOX regimen were higher than in patients with breast cancer, in patients treated with cyclophosphamid, in patients treated with AC regimen, with respectively statistically significant differences (OR: 2.31; 95% CI: 1.39-3.87; p<0.01); (OR: 2.15; 95% CI: 1.28-3.61; p<0.01); (OR: 2.06; 95% CI: 1.21-3.48; p<0.01). Increased plasma glucose levels after chemotherapy. Plasma glucose levels changed differently by tumor types chemotherapeutic agents and regimens. After the 3rd cycle, the prediabetes, diabetes were 19.9% and 3.4%.
Keywords
Full Text:
PDF (Tiếng Việt)References
[1]. J. Yang, B. Jia, Y. Qiao, W. Chen, and X. Qi, “Variations of blood glucose in cancer patients during chemotherapy,” Nigerian Journal of Clinical Practice, vol. 19, no. 6, pp. 704-708, 2016.
[2]. G. Y. Ji, L. B. Jin, and R. J. Wang, “Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment,” Med Oncol, vol. 30, pp. 687-690, 2013.
[3]. Monzavi-Karbassi et al, “Pre-diagnosis blood glucose and prognosis in women with breast cancer,” Cancer & Metabolism, vol. 4, no. 7, pp. 1-6, 2016.
[4]. Ministry of Health, Guidelines for the diagnosis and treatment of cancer at Decision 3338/QĐ-BYT, September, 2013.
[5]. M. A. Weiser, M. E. Cabanillas, and M. Konopleva, “Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/ methotrexate-cytarabine regimen,” Cancer, vol. 100, pp. 1179-1185, 2004.
[6]. R. Mohammed, and R. J. Kumar, “Interrelationship of BMI and steroids on glycaemic levels in patient on chemotherapy,” International Journal of Research in Medical Sciences, vol. 4, no. 2, pp. 491-494, 2016.
[7]. D. S. Sheriff, “Glucose Intolerance During Adjuvant Chemotherapy for Breast Cancer,” J Cancer Prev Curr Res, vol. 6, no. 1, pp. 102-103, 2016.Refbacks
- There are currently no refbacks.